Looking Into Otonomy's Return On Capital Employed

During Q1, Otonomy's OTIC reported sales totaled $90.00 thousand. Despite a 15.13% in earnings, the company posted a loss of $11.84 million. Otonomy collected $53.00 thousand in revenue during Q4, but reported earnings showed a $10.29 million loss.

What Is ROCE?

Changes in earnings and sales indicate shifts in Otonomy's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q1, Otonomy posted an ROCE of -0.21%.

It is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future.

Return on Capital Employed is an important measurement of efficiency and a useful tool when comparing companies that operate in the same industry. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders.

In Otonomy's case, the ROCE ratio shows the amount of assets may not be helping the company achieve higher returns. Investors may take this into account before making any long-term financial decisions.

Q1 Earnings Insight

Otonomy reported Q1 earnings per share at $-0.23/share, which did not meet analyst predictions of $-0.21/share.

Market News and Data brought to you by Benzinga APIs
Posted In: NewsBZI-ROCE
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!